APA (7th ed.) Citation

J, D. M., F, F., N, P., MM, V., B, K., C, D. B., . . . P, G. (2026). Cost-Utility Analysis of Control-IQ Technology Relative to Conventional Insulin Therapy in Adults with Type 1 Diabetes. Diabetes technology & therapeutics, 28(7), 717. https://doi.org/10.1177/15209156251408041

Chicago Style (17th ed.) Citation

J, De Meulemeester, et al. "Cost-Utility Analysis of Control-IQ Technology Relative to Conventional Insulin Therapy in Adults with Type 1 Diabetes." Diabetes Technology & Therapeutics 28, no. 7 (2026): 717. https://doi.org/10.1177/15209156251408041.

MLA (9th ed.) Citation

J, De Meulemeester, et al. "Cost-Utility Analysis of Control-IQ Technology Relative to Conventional Insulin Therapy in Adults with Type 1 Diabetes." Diabetes Technology & Therapeutics, vol. 28, no. 7, 2026, p. 717, https://doi.org/10.1177/15209156251408041.